Physician at Baton Rouge General Among First to Perform New Stroke Prevention Procedure

Minimally invasive technology temporarily reverses brain blood flow, treats carotid artery disease

Baton Rouge, La. – Recently, a patient at Baton Rouge General was among the first in the country to benefit from a new stroke prevention procedure. Dr. Vince Weaver, a vascular surgeon with Baton Rouge Vascular Specialty Center, is the first physician in South Louisiana and the only physician in Baton Rouge to perform a new, minimally invasive procedure that reverses the blood flow through the brain to divert blood clots and plaque away from the brain to prevent blockage and stroke.

“Strokes can be tragic and life-altering, and I’m thrilled to be able to offer such an important new option in the fight against them,” said Dr. Weaver. “TCAR is particularly suited for the large portion of patients we see who are at higher risk of complications from other traditional procedures. Because of the TCAR procedure’s low stroke risk, we think it has the potential to become the standard of care for all patients.”

In this new minimally invasive procedure, called TransCarotid Artery Revascularization or TCAR, through a small incision at the base of the neck, physicians temporarily reverse the blood flow in the carotid artery prior to placing a stent in one of the patient’s neck arteries to prevent blockage from clogging arteries and potentially leading to stroke.

“TCAR is able to provide patients with the safest possible treatment option for patients with carotid artery disease,” said Dr. Weaver.

Before this procedure, the main treatment option for high risk patients with blocked carotid arteries was open surgery, which increases risk of stroke, heart attack, and cranial nerve injuries that can cause issues with swallowing, speaking, and sensation in the face. The alternate procedure for patients with previous neck surgery, difficult anatomy or radiation treatment has an even higher risk of stroke.

In addition to lower risk, patients can also expect a faster and less painful recovery with TCAR. Dr. Weaver said, “The hour-long surgery went smoothly, and we expect TCAR patients to be discharged from the hospital the morning after surgery.”

Every year, 15 million people worldwide suffer from strokes. Nearly six million die and another five million are left permanently disabled. Stroke is the second leading cause of disability worldwide, and is the number four cause of death in Louisianians each year. Carotid artery disease is estimated to be the source of stroke in up to a third of cases.

To learn more about stroke prevention and the TCAR procedure, register at BRGeneral.org for a free lunch seminar at BRG on September 5.

About Baton Rouge General Medical Center
Baton Rouge General Medical Center is the area’s first community hospital with 588 licensed beds between two campuses. Baton Rouge General opened its doors in 1900, and has provided the Greater Baton Rouge community with high-quality healthcare for generations. An accredited teaching hospital since 1991, Baton Rouge General serves as a satellite campus of Tulane University School of Medicine, and offers other medical education programs, including a School of Nursing, School of Radiologic Technology, Family Medicine Residency Program, Internal Medicine Residency Program, and Sports Medicine Fellowship Program. For more information, visit BRGeneral.org, find us on Facebook at Facebook.com/BatonRougeGeneral and follow us on Twitter at @BRGeneral.

About Vascular Specialty Center
Baton Rouge Vascular Specialty Center (VSC) provides care from fellowship-trained, board-certified, experienced leaders in vascular care who have served Baton Rouge and southern Louisiana with distinction for more than 30 years. Our professional, friendly vascular team has helped thousands of patients just like you. For more information, visit brvsc.com or call 225-399-4472.

About TCAR with the ENROUTE Transcarotid Neuroprotection and Stent System The ENROUTE® Transcarotid Neuroprotection (NPS) and Stent System from Silk Road Medical, Inc. are the first devices designed and FDA-approved specifically for TCAR. The ENROUTE Transcarotid Stent is indicated for use in High Surgical Risk patients and is intended to be used in conjunction with the ENROUTE Transcarotid Neuroprotection System (NPS). The ENROUTE Transcarotid NPS is used to directly access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting the ENROUTE Transcarotid Stent.

Categories: Company News